Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Updating Product Endorsement Rules; Asks Rx Industry To Comment

Executive Summary

The Federal Trade Commission wants comments from the pharmaceutical industry about its guidelines governing paid product endorsements, Division of Advertising Practices Assistant Director Thomas Pahl told a Food & Drug Law Institute conference Sept. 12 in Washington, D.C
Advertisement

Related Content

DTC Guidances Could Limit Use Of Celebrity Endorsers Outside Of Product Ads
DTC Guidances Could Limit Use Of Celebrity Endorsers Outside Of Product Ads
Print Ads Should Use Limited “Brief Summary” Like TV Spots, FTC Tells FDA
Print Ads Should Use Limited “Brief Summary” Like TV Spots, FTC Tells FDA
MERCK PRINIVIL RIPKEN ADS NEED STRONGER DISCLAIMER, FDA TELLS COMPANY; GEMZAR PROMOTIONS, CLARITIN 1-800 LINE, ULTANE JOURNAL ADS RUN AFOUL OF FDA
MERCK PRINIVIL RIPKEN ADS NEED STRONGER DISCLAIMER, FDA TELLS COMPANY; GEMZAR PROMOTIONS, CLARITIN 1-800 LINE, ULTANE JOURNAL ADS RUN AFOUL OF FDA
Advertisement
UsernamePublicRestriction

Register

PS042536

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel